CTNND1 and colorectal carcinoma: Similarly, miR-425 was discovered to play positive roles in not only promoting tumorigenesis and metastasis through activating CTNND1-mediated β-catenin pathway in CRC but also facilitating CRC chemoresistance by targeting PDCD10 (15, 54).